These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27699467)

  • 41. High prevalence of ATTR amyloidosis in endomyocardial biopsy-proven cardiac amyloidosis patients.
    Nakagawa M; Sekijima Y; Tojo K; Ikeda S
    Amyloid; 2013 Jun; 20(2):138-40. PubMed ID: 23638696
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful perioperative use of prothrombin complex concentrate in the treatment of acquired factor X deficiency in the setting of systemic light-chain (AL) amyloidosis.
    Litvak A; Kumar A; Wong RJ; Smith L; Hassou H; Soff G
    Am J Hematol; 2014 Dec; 89(12):1153-4. PubMed ID: 25060940
    [No Abstract]   [Full Text] [Related]  

  • 43. Isaacs' syndrome as a potassium channelopathy of the nerve.
    Arimura K; Sonoda Y; Watanabe O; Nagado T; Kurono A; Tomimitsu H; Otsuka R; Kameyama M; Osame M
    Muscle Nerve Suppl; 2002; 11():S55-8. PubMed ID: 12116286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of clinical and echocardiographic characteristics on occurrence of cardiac events in cardiac amyloidosis as proven by endomyocardial biopsy.
    Nakahashi T; Arita T; Yamaji K; Inoue K; Yokota T; Hoshii Y; Fukunaga M; Nomura A; Watanabe H; Miura S; Isotani A; Soga Y; Ando K; Iwabuchi M; Yokoi H; Nosaka H; Yamagishi M; Nobuyoshi M
    Int J Cardiol; 2014 Oct; 176(3):753-9. PubMed ID: 25131905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immune-mediated neuromyotonia (Isaacs' syndrome)--clinical aspects and pathomechanism].
    Arimura K; Watanabe O
    Brain Nerve; 2010 Apr; 62(4):401-10. PubMed ID: 20420181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endoscopic treatment for esophageal varices complicated by Isaacs' syndrome involving difficulty with conventional sedation.
    Suzuki Y; Yamazaki Y; Hashizume H; Kobayashi T; Ohyama T; Horiguchi N; Sato K; Kakizaki S; Kusano M; Yamada M
    Clin J Gastroenterol; 2016 Feb; 9(1):27-31. PubMed ID: 26862027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nodular primary cutaneous amyloidosis. Isolation and characterization of amyloid fibrils.
    Kitajima Y; Seno J; Aoki S; Tada S; Yaoita H
    Arch Dermatol; 1986 Dec; 122(12):1425-30. PubMed ID: 3789778
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of rapidly progressive liver light chain deposition under VAD chemotherapy in multiple myeloma.
    Samanez C; Domingo A; Cibeira MT; Miquel R; Soler M; Bladé J
    Eur J Haematol; 2006 Jan; 76(1):83-5. PubMed ID: 16343276
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myopathy associated with amyloid angiopathy.
    Bruni J; Bilbao JM; Pritzker PH
    Can J Neurol Sci; 1977 Feb; 4(1):77-80. PubMed ID: 837267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical, endoscopic, and histopathological features of localized immunoglobulin light chain (AL) amyloidosis in the gastrointestinal tract.
    Katoh N; Matsuda M; Ikeda S
    Amyloid; 2015; 22(4):254-6. PubMed ID: 26403136
    [No Abstract]   [Full Text] [Related]  

  • 51. Peritoneal amyloidosis with myopathy in primary systemic (AL) amyloidosis.
    Al-Adhami A; Steiner K; Ellis S
    BMJ Case Rep; 2017 Feb; 2017():. PubMed ID: 28188164
    [No Abstract]   [Full Text] [Related]  

  • 52. Isolated nasal amyloidosis: a case report.
    Rauba D; Lesinskas E; Petrulionis M; Sukytė D; Valevičienė N; Palionis D; Tamošiūnas A
    Medicina (Kaunas); 2013; 49(11):497-503. PubMed ID: 24823932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fatal bleeding due to acquired factor IX and X deficiency: a rare complication of primary amyloidosis; case report and review of the literature.
    Ericson S; Shah N; Liberman J; Aboulafia DM
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):e81-6. PubMed ID: 24290671
    [No Abstract]   [Full Text] [Related]  

  • 54. Amyloidosis causing a progressive myopathy.
    Nadkarni N; Freimer M; Mendell JR
    Muscle Nerve; 1995 Sep; 18(9):1016-8. PubMed ID: 7643863
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pinch Purpura: A Cutaneous Manifestation of Systemic Amyloidosis.
    Agarwal A; Chang DS; Selim MA; Penrose CT; Chudgar SM; Cardones AR
    Am J Med; 2015 Sep; 128(9):e3-4. PubMed ID: 25910788
    [No Abstract]   [Full Text] [Related]  

  • 56. Myocardial infarction with "clean coronaries" caused by amyloid light-chain AL amyloidosis: a case report and literature review.
    Tsai SB; Seldin DC; Wu H; O'Hara C; Ruberg FL; Sanchorawala V
    Amyloid; 2011 Sep; 18(3):160-4. PubMed ID: 21504342
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Axial myopathy due to primary amyloidosis.
    Friedman Y; Paul JT; Turley J; Hazrati LN; Munoz D
    Muscle Nerve; 2007 Oct; 36(4):542-6. PubMed ID: 17405139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exceptional oral manifestations of amyloid light chain protein (AL) systemic amyloidosis.
    Elad S; Czerninski R; Fischman S; Keshet N; Drucker S; Davidovich T; Goldschmidt N
    Amyloid; 2010 Mar; 17(1):27-31. PubMed ID: 20146645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mucocutaneous bullous amyloidosis with an unusual mixed protein composition of amyloid deposits.
    Rekhtman N; Hash KS; Moresi JM
    Br J Dermatol; 2006 Apr; 154(4):751-4. PubMed ID: 16536823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Familial amyloidosis with polyneuropathy presenting restrictive cardiomyopathy as its main manifestation].
    Yoshioka J; Homma T; Furuta S; Hongo M; Okubo S; Kusama S; Ikeda S; Yanagisawa N; Yoshizawa S
    Nihon Naika Gakkai Zasshi; 1984 May; 73(5):622-31. PubMed ID: 6491439
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.